Iradimed annual gross margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Iradimed's gross margin was 76.75% for fiscal 2025.
View full Iradimed company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 76.75% | −0.19 pp |
| 2024 | 2024-12-31 | 76.94% | +0.43 pp |
| 2023 | 2023-12-31 | 76.50% | −0.94 pp |
| 2022 | 2022-12-31 | 77.45% | +0.80 pp |
| 2021 | 2021-12-31 | 76.65% | +2.32 pp |
| 2020 | 2020-12-31 | 74.33% | −2.78 pp |
| 2019 | 2019-12-31 | 77.11% | +0.80 pp |
| 2018 | 2018-12-31 | 76.31% | +0.44 pp |
| 2017 | 2017-12-31 | 75.87% | −5.19 pp |
| 2016 | 2016-12-31 | 81.06% | −0.45 pp |
| 2015 | 2015-12-31 | 81.51% | +3.26 pp |
| 2014 | 2014-12-31 | 78.25% | +3.41 pp |
| 2013 | 2013-12-31 | 74.84% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 74.07% | −4.10 pp |
| Q1 2026 | 2026-03-31 | 76.50% | +0.43 pp |
| Q4 2025 | 2025-12-31 | 75.06% | −1.07 pp |
| Q3 2025 | 2025-09-30 | 77.80% | +0.36 pp |
| Q2 2025 | 2025-06-30 | 78.18% | +0.04 pp |
| Q1 2025 | 2025-03-31 | 76.08% | +0.00 pp |
| Q4 2024 | 2024-12-31 | 76.13% | −0.72 pp |
| Q3 2024 | 2024-09-30 | 77.44% | −0.34 pp |
| Q2 2024 | 2024-06-30 | 78.14% | +2.59 pp |
| Q1 2024 | 2024-03-31 | 76.07% | +0.33 pp |
| Q4 2023 | 2023-12-31 | 76.86% | +1.37 pp |
| Q3 2023 | 2023-09-30 | 77.78% | −0.85 pp |
| Q2 2023 | 2023-06-30 | 75.55% | −4.16 pp |
| Q1 2023 | 2023-03-31 | 75.74% | −0.45 pp |
| Q4 2022 | 2022-12-31 | 75.49% | −2.42 pp |
| Q3 2022 | 2022-09-30 | 78.63% | +1.57 pp |
| Q2 2022 | 2022-06-30 | 79.71% | +4.97 pp |
| Q1 2022 | 2022-03-31 | 76.19% | −0.37 pp |
| Q4 2021 | 2021-12-31 | 77.91% | +2.56 pp |
| Q3 2021 | 2021-09-30 | 77.06% | +2.50 pp |
| Q2 2021 | 2021-06-30 | 74.74% | +2.18 pp |
| Q1 2021 | 2021-03-31 | 76.56% | +2.08 pp |
| Q4 2020 | 2020-12-31 | 75.35% | +0.53 pp |
| Q3 2020 | 2020-09-30 | 74.57% | −3.67 pp |
| Q2 2020 | 2020-06-30 | 72.56% | −7.30 pp |
| Q1 2020 | 2020-03-31 | 74.49% | −1.24 pp |
| Q4 2019 | 2019-12-31 | 74.82% | −1.40 pp |
| Q3 2019 | 2019-09-30 | 78.24% | +2.23 pp |
| Q2 2019 | 2019-06-30 | 79.86% | +3.05 pp |
| Q1 2019 | 2019-03-31 | 75.73% | −0.47 pp |
| Q4 2018 | 2018-12-31 | 76.23% | +0.69 pp |
| Q3 2018 | 2018-09-30 | 76.01% | −1.00 pp |
| Q2 2018 | 2018-06-30 | 76.81% | −0.85 pp |
| Q1 2018 | 2018-03-31 | 76.20% | +3.08 pp |
| Q4 2017 | 2017-12-31 | 75.54% | −2.69 pp |
| Q3 2017 | 2017-09-30 | 77.02% | −4.66 pp |
| Q2 2017 | 2017-06-30 | 77.66% | −4.72 pp |
| Q1 2017 | 2017-03-31 | 73.12% | −7.85 pp |
| Q4 2016 | 2016-12-31 | 78.23% | −4.72 pp |
| Q3 2016 | 2016-09-30 | 81.68% | +1.09 pp |
| Q2 2016 | 2016-06-30 | 82.38% | +1.07 pp |
| Q1 2016 | 2016-03-31 | 80.97% | −0.03 pp |
| Q4 2015 | 2015-12-31 | 82.95% | +8.59 pp |
| Q3 2015 | 2015-09-30 | 80.59% | +5.77 pp |
| Q2 2015 | 2015-06-30 | 81.31% | −0.18 pp |
| Q1 2015 | 2015-03-31 | 81.00% | −0.54 pp |
| Q4 2014 | 2014-12-31 | 74.36% | +1.37 pp |
| Q3 2014 | 2014-09-30 | 74.83% | +2.49 pp |
| Q2 2014 | 2014-06-30 | 81.50% | — |
| Q1 2014 | 2014-03-31 | 81.55% | — |
| Q3 2013 | 2013-09-30 | 72.99% | — |
| Q2 2013 | 2013-06-30 | 72.33% | — |
Over the last five reported fiscal years, Iradimed's gross margin increased from 74.33% to 76.75%, a change of +2.42 percentage points. The latest reported quarter, Q2 2026, shows 74.07%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Iradimed filings at SEC.gov ↗